Cargando…
Synergistic cortisol suppression by ketoconazole–osilodrostat combination therapy
SUMMARY: Here, we describe a case of a patient presenting with adrenocorticotrophic hormone-independent Cushing’s syndrome in a context of primary bilateral macronodular adrenocortical hyperplasia. While initial levels of cortisol were not very high, we could not manage to control hypercortisolism w...
Autores principales: | Amodru, Vincent, Brue, Thierry, Castinetti, Frederic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686175/ https://www.ncbi.nlm.nih.gov/pubmed/34877930 http://dx.doi.org/10.1530/EDM-21-0071 |
Ejemplares similares
-
Osilodrostat in Cushing’s disease: the management of its efficacy and the pitfalls of post-surgical results
por: Antonini, Simone, et al.
Publicado: (2022) -
Severe Cushing’s syndrome from an ectopic adrenocorticotropic hormone-secreting neuroendocrine tumour treated by osilodrostat
por: Hána, Václav, et al.
Publicado: (2023) -
Long-term low-dose ketoconazole treatment in bilateral macronodular adrenal hyperplasia
por: Comte-Perret, Sophie, et al.
Publicado: (2014) -
Adrenal Crisis May Occur Even In Patients With Asymptomatic Covid-19
por: Castinetti, Frederic, et al.
Publicado: (2020) -
Thyroid dermopathy responds to teprotumumab therapy
por: Crespo-Trevino, Ricaurte, et al.
Publicado: (2022)